ByAUJay
Summary: There’s no widely listed “Intavallous” token. The closest live market match is Intiva Token (ticker: TIVA), a BEP‑20 utility/rewards asset tied to Intiva Health’s Incredable credentialing platform. Below we cover TIVA’s price today (January 7, 2026), its on‑chain and market structure, and a pragmatic 2026 scaling outlook for enterprise decision‑makers.
Intavallous Token Price Today and Price Forecast: Can This Token Scale in 2026?
Before we dive in: “Intavallous” doesn’t show up on major market trackers. The token decision‑makers are actually encountering in the wild is Intiva Token, ticker TIVA, which lives on BNB Chain and underpins Intiva Health’s healthcare‑compliance incentives. We’ll analyze TIVA because it’s the active, listed asset that matches the context and intent of the query. (coingecko.com)
Price today (January 7, 2026) at a glance
- Global aggregated price (CoinGecko): $0.0946, 24h range $0.0936–$0.0952; FDV ~$94.4M; tracked on one exchange. (coingecko.com)
- MEXC spot (exchange live page): $0.0919; 24h volume ~$230.8K; FDV ~$91.9M; total supply 1,000,000,000 TIVA. (mexc.com)
- Coinranking snapshot (MEXC): $0.0916; 24h volume ~$227K; contract: BSC 0x57b13a7e18d7382f2ce754ff112b2f552230b83e. (coinranking.com)
Why the small spread? Aggregators compute volume‑weighted global prices and can lag the underlying exchange feed by minutes; MEXC shows its book in near‑real‑time. For treasury planning, we recommend anchoring to the venue where you’ll execute (MEXC) and using an external VWAP as a reasonableness check. (mexc.com)
Key identifiers:
- Chain: BNB Chain (BEP‑20)
- Contract: 0x57b13a7e18d7382f2ce754ff112b2f552230b83e
- Active market: MEXC, pair TIVA/USDT, live since December 5, 2025, 13:00 UTC. (coingecko.com)
What TIVA actually is
TIVA is a utility/rewards token integrated into Intiva Health’s Incredable credentialing platform. Licensed medical professionals and facilities earn TIVA for verified actions—logging in, uploading credentials, completing verification steps, renewals—and can spend TIVA on CME courses, malpractice insurance, marketplace services and partner discounts. The token site emphasizes a fixed total supply of 1,000,000,000 and states no additional TIVA will be created. (token.intivahealth.com)
The Incredable website links TIVA as a first‑class component of the solution, confirming product‑level integration rather than a bolt‑on token gimmick. (incredable.com)
On‑chain and market structure (the details that matter)
- Live activity on January 7, 2026: The token contract shows recent transfers; BscScan lists 12,701 total transactions and identifies MEXC wallets moving tokens to the contract—useful signals that exchange settlement and token flows are active. (bscscan.com)
- Exchange concentration: CoinGecko currently tracks only one centralized exchange (MEXC) for TIVA, so liquidity is exchange‑concentrated and venue risk is material. (coingecko.com)
- Listing timeline: MEXC listed TIVA/USDT on December 5, 2025 (Innovation Zone), with deposits open before go‑live and withdrawals on December 6, 2025. (mexc.fm)
- Price extremes:
- CoinGecko ATH: $0.1049 on December 22, 2025; ATL: $0.09023 on December 27, 2025. (coingecko.com)
- Coinranking cites a higher ATH ($0.138) on December 8, 2025—differences stem from data sources and calculation methodologies. (coinranking.com)
- Tokenomics highlights from the project:
- Fixed total supply: 1,000,000,000 TIVA; company states it will not create more.
- Distribution is tied to real platform actions for Licensed Medical Professionals (LMPs) over 3–5 years; Facilities/Medical Groups (FMGs) earn via platform participation.
- A 0.5%–2% fee is applied on certain purchases made with TIVA and redistributed to sustain rewards. (token.intivahealth.com)
- Security posture: The project links a Hashlock smart‑contract audit (November 2025) with a “Secure” rating; press coverage reiterates that findings were resolved or addressed. Always review the PDF yourself and validate scope. (hashlock.com)
What this means for an enterprise or startup:
- With liquidity largely at MEXC, large orders may move price. Use TWAP/VWAP execution or RFQ with market makers if you need size. (mexc.com)
- Emissions are utility‑driven (actions on Incredable). As platform activity scales, circulating supply should gradually increase—plan for emissions over a 3–5 year window. (token.intivahealth.com)
- The audit is a plus, but treat it as “a point in time.” Build your own custody/policy controls regardless of audit status. (hashlock.com)
Today’s price context in one screen for executives
- As of January 7, 2026, TIVA trades around nine to ten cents across feeds, with intraday volatility sub‑3% and volume between ~$95K (CoinGecko aggregated) and ~$231K (MEXC’s book). That’s low to moderate turnover for a single‑venue, early‑stage utility token. (coingecko.com)
Fundamentals: Is there real product‑market fit behind the token?
- Product integration: TIVA is embedded into Incredable workflows (credentialing, renewals, PSV), so earning is tied to verifiable work, not pure speculation. (incredable.com)
- Redeemability: CME, malpractice insurance, medical devices, marketplace services, and partner discounts are cited redemption areas—i.e., value flows back into operational needs for providers. (token.intivahealth.com)
- Ecosystem linkages: Intiva Health positions TIVA as the incentive layer across Incredable, Nova Vita clinics, and Gummi World nutraceuticals over time—i.e., potential multi‑business interoperability. (token.intivahealth.com)
Practical example: How a multi‑site clinic could operationalize TIVA in Q1 2026
- Scope: 150 providers across 8 locations.
- Incentive design: Award TIVA for credential submissions completed on time, renewal completions >30 days before expiry, and clean audit logs (no missing documents).
- Redemption: Providers can apply TIVA toward CME bundles or malpractice premium credits, lowering facility reimbursements. (token.intivahealth.com)
- Controls:
- Custody: Use an institutional wallet with role‑based approvals (MPC or HSM).
- Accounting: Tag every reward issuance with a workflow ID from Incredable so finance can attribute token spend to compliance KPIs. (incredable.com)
- Market risk: Source TIVA inventory weekly via scheduled TWAP on MEXC, with circuit breakers if slippage >1.5%. (mexc.com)
2026 scaling thesis: What needs to go right
- Distribution and emissions must correlate with verified, high‑value actions
- The 3–5 year LMP emission runway is long enough to bootstrap behavior but short enough to avoid perpetual inflation narratives—provided the platform continues adding verifiable actions and sinks. (token.intivahealth.com)
- Sinks matter as much as sources
- The 0.5%–2% recirculation fee on TIVA‑denominated purchases helps sustain rewards, but the bigger lever is expanding redemption into habitual spend (CME subscriptions, device/kit purchases, service seats). (token.intivahealth.com)
- Liquidity diversification
- A second CEX or a reputable DEX pool on BNB Chain would reduce venue risk and improve price discovery. Right now, CoinGecko shows MEXC as the only tracked market. (coingecko.com)
- Compliance and security signaling
- Continued public audits (code and tokenomics) plus operational attestations (KYB for large partners) shrink procurement friction for hospitals and payers. The Hashlock audit is a starting point. (hashlock.com)
- Clear, credible comms cadence
- Regular issuer updates around on‑platform metrics (e.g., monthly verified credentials processed, active providers, redemption mix) will help enterprises justify integrating TIVA internally.
Price forecast: data‑informed scenarios for 2026
We don’t do hype targets. Below are decision‑grade views that blend third‑party models with pragmatic operating assumptions.
-
External TA‑driven baseline: CoinCodex’s model (as of late December 2025) projected a short‑term dip toward ~$0.072 in January 2026 and a 12‑month target around ~$0.207 by December 22, 2026. Treat these as technical projections, not fundamentals. (coincodex.com)
-
Executive scenarios you can plan around:
- Bear case (venue concentration persists):
- No additional listings; emissions outpace organic sinks; price mean‑reverts toward the low 0.07s; spreads widen around event days. Procurement impact: top up inventory only on execution need; avoid large advance purchases. (coincodex.com)
- Base case (measured growth):
- One additional liquid venue or a credible DEX pool; monthly platform metrics show steady LMP/FM G activity; price stabilizes in the $0.08–$0.12 channel with improving depth. Procurement impact: set monthly TWAPs and rebalance treasury exposure quarterly. (coingecko.com)
- Bull case (utility flywheel):
- Redemptions expand (CME bundles, malpractice credits) and clinics adopt TIVA‑backed compliance incentives; net demand > emissions; price challenges the December highs and extends beyond, contingent on broader market risk. Procurement impact: pre‑fund reward pools ahead of peak renewal seasons. (token.intivahealth.com)
- Bear case (venue concentration persists):
Remember: single‑asset forecasts are path‑dependent. Your operational ROI from compliance behaviors can be positive even if price is sideways, provided TIVA translates into measurable throughput, fewer expirations, and lower administrative hours.
Emerging best practices for enterprises piloting TIVA‑style incentives
- Tie tokens to verifiable events only
- Use Incredable workflow IDs as the source of truth; avoid manual grant paths. This limits gaming and simplifies audits. (incredable.com)
- Treasury and custody
- Segregate a rewards wallet with spend policies and just‑in‑time top‑ups from a cold treasury.
- Pre‑approve counterparties and set slippage guards for MEXC execution. (mexc.com)
- Emissions discipline
- Align reward sizes to task value and scarcity. Use the 0.5%–2% recirculation mechanic to recycle value, but monitor if it impacts user willingness to pay in TIVA. (token.intivahealth.com)
- Measurement
- Track: time‑to‑credential, document error rate, renewal lead time, and CME completion rates. Compare cohorts with and without TIVA incentives.
- Legal/finance checkpoints (U.S. context)
- Coordinate with counsel on tax reporting for rewards and with compliance on any anti‑kickback or inducement considerations in healthcare contexts; classify TIVA holdings and flows in your accounting policy accordingly.
- Security hygiene
- Don’t outsource risk to audits. Enforce allow‑listed addresses, hardware‑secured signers, and dual approvals for transfers. If you’re integrating smart contracts, commission your own audit.
Red flags and mitigations
- Single‑venue liquidity risk
- Mitigation: accumulate via scheduled TWAP; seek OTC/RFQ with market makers; push for secondary listings / DEX depth. (coingecko.com)
- Data discrepancies across trackers (ATH/volume deltas)
- Mitigation: standardize your internal dashboards on one data source (e.g., direct exchange feed + a single aggregator) and document the methodology. (coingecko.com)
- Contract control assumptions
- Even with audits, confirm contract ownership/privileges and any upgradability/minting flags in your own diligence before committing budgets. (hashlock.com)
Implementation blueprint (first 90 days)
- Weeks 0–2
- Risk and procurement sign‑offs; create MPC wallet; define rewardable actions; establish issuance policy and limits.
- Weeks 3–6
- Integrate with Incredable; tag reward events with workflow IDs; pilot with one department; begin weekly TWAP purchases on MEXC within a defined slippage budget. (incredable.com)
- Weeks 7–12
- Expand to all locations; launch a redemption catalog (CME/insurance/device bundles); publish a monthly compliance KPI report to execs; adjust reward calibration based on observed behavior. (token.intivahealth.com)
Bottom line for 2026
- TIVA’s utility story is credible because it’s anchored to a live credentialing platform and real healthcare spend categories. The token has an audit trail, a clear supply cap, and a defined emissions cadence tied to verifiable actions. (incredable.com)
- The constraints are equally clear: single‑venue liquidity, evolving circulating supply disclosures, and the need for consistent enterprise‑grade reporting. Addressing these will determine whether TIVA scales beyond a niche rewards asset in 2026. (coingecko.com)
If by “Intavallous” you were referring to another asset, it’s not visible on major trackers as of January 7, 2026. For practical purposes, the healthcare‑incentive token decision‑makers are facing today is Intiva Token (TIVA)—and you now have the operational playbook to evaluate and pilot it. (coingecko.com)
References and source checks:
- TIVA live price, FDV, and markets (CoinGecko). (coingecko.com)
- MEXC live price/volume and listing details. (mexc.com)
- Coinranking market snapshot and contract. (coinranking.com)
- Intiva Health company site and TIVA token site (tokenomics, rewards, roadmap). (intivahealth.com)
- Incredable platform link to TIVA. (incredable.com)
- BscScan contract activity (Jan 7, 2026). (bscscan.com)
- Hashlock audit page and coverage. (hashlock.com)
- External prediction models (context only). (coincodex.com)
Disclaimer: This article is for information only and not investment, legal, or tax advice. Always do your own due diligence.
Like what you're reading? Let's build together.
Get a free 30‑minute consultation with our engineering team.

